4′-Ethynyl nucleoside analogues: Potent inhibitors active against multi-drug-resistant HIV variants

International Antiviral News

Volumn 9, Issue 8, 2001, Pages 128-132

  Kodama, Eiichi ^a   Matsuoka, Masao ^a   Ohrui, Hiroshi ^a   Mitsuya, Hiroaki ^a  

^a KYOTO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

2',3' DIDEOXYRIBOFURANOSE; 4' ETHYLTHYMIDINE; 4' ETHYNYL 2' DEOXYADENOSINE; 4' ETHYNYL 2' DEOXYCYTIDINE; 4' ETHYNYL 2' DEOXYGUANOSINE; 4' ETHYNYL 2' DEOXYNUCLEOSIDE DERIVATIVE; 4' ETHYNYL 2' DEOXYRIBOFURANOSYL 2,6 DIAMINOPURINE; 4' ETHYNYLARABINOFURANOSYLCYTOSINE; 4' ETHYNYLTHYMIDINE; 4' FLUOROMETHYL 2' DEOXYCYTIDINE; 4' HYDROXYETHYLTHYMIDINE; 4' METHYL 2' DEOXYCYTIDINE; 4' VINYLTHYMIDINE; ADEFOVIR; DIDANOSINE; FURAN DERIVATIVE; HYDROXYL GROUP; LAMIVUDINE; NUCLEOSIDE DERIVATIVE; RIBOSE; RNA DIRECTED DNA POLYMERASE INHIBITOR; STAVUDINE; TENOFOVIR; UNCLASSIFIED DRUG; VIRUS DNA; ZALCITABINE; ZIDOVUDINE;

ANTIVIRAL ACTIVITY; CONTROLLED STUDY; DRUG ACTIVITY; DRUG MECHANISM; DRUG STABILITY; DRUG STRUCTURE; HUMAN IMMUNODEFICIENCY VIRUS 1; IN VITRO STUDY; MULTIDRUG RESISTANCE; NONHUMAN; REVIEW; STRUCTURE ACTIVITY RELATION; VIRUS INHIBITION; VIRUS RESISTANCE;

EID: 0035710761     PISSN: 09652310     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (20)

1. Strategies for antiviral therapy in AIDS
2. Discovery and development of antiretroviral therapeutics for HIV infection
3. Synthesis and anti-HIV activity of 4′-azido- and 4′-methoxynucleosides
4. Synthesis of 4′-cyanothymidine and analogs as potent inhibitors of HIV
5. Solid-state and solution conformations of the potent HIV inhibitor, 4′-azidothymidine
6. Selective action of 4′-azidothymidine triphosphate on reverse transcriptase of human immunodeficiency virus type 1 and human DNA polymerases alpha and beta
7. Synthesis of 4′-C-ethynyl-b-D-arabino- and 4′-C-ethynyl-2′-deoxy-β D-ribo-pentofuranosyl pyrimidines and purines and evaluation of their anti HIV-1 activity
8. 4′-Ethynyl nucleoside analogs: Potent inhibitors of multidrug-resistant human immunodeficiency virus variants in vitro
9. Perspectives of non-nucleoside reverse transcriptase inhibitors (NNRTIs) in the therapy of HIV-1 infection
10. Detection of replication-competent and pseudotyped human immunodeficiency virus with a sensitive cell line on the basis of activation of an integrated beta-galactosidase gene
11. Evolution and fitness of HIV-1 with the pol gene mutations conferring multi-dideoxynucleoside resistance
12. Emergence of human immunodeficiency virus type-1 variants with resistance to multiple dideoxynucleosides in patients receiving therapy with dideoxynucleosides
13. A 6-basepair insert in the reverse transcriptase gene of human immunodeficiency virus type 1 confers resistance to multiple nucleoside inhibitors
14. JE-2147: A dipeptide protease inhibitor (PI) that potently inhibits multi-PI-resistant HIV 1
15. Potent and selective inhibition of human immunodeficiency virus type 1 (HIV-1) by 5-ethyl-6-phenylthiouracil derivatives through their interaction with the HIV 1 reverse transcriptase
16. Potent and selective inhibition of human immunodeficiency virus (HIV)-1 and HIV-2 replication by a class of bicyclams interacting with a viral uncoating event
17. Antiretroviral treatment for HIV infection
18. Structure of a covalently trapped catalytic complex of HIV-1 reverse transcriptase: Implications for drug resistance
19. Lamivudine (3TC) resistance in HIV-1 reverse transcriptase involves steric hindrance with beta-branched amino acids
20. Touching the heart of HIV-1 drug resistance: The fingers close down on the dNTP at the polymerase active site